Evidence map›Paper›PMID 37484745›Full record

ArticleClinical case reports2023

Fatal vanishing bile duct syndrome in Iranian patient with Hodgkin's lymphoma.

Fazlollah Shokri, Aref Shariati, Arash Kazemi Veisari, Amirhossein Kianezhad, Somayeh Sheidaei, Ali Asghar Alamian, Hossein Sadeghi, Mohsen Heidary

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Fazlollah ShokriDepartment of Medical Genetics, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.
Aref ShariatiMolecular and Medicine Research Center Khomein University of Medical Sciences Khomein Iran.
Arash Kazemi VeisariDepartment of Internal Medicine, Gut and Liver Research Center, School of Medicine Mazandaran University of Medical Sciences Sari Iran.
Amirhossein KianezhadFaculty of Medicine Mazandaran University of Medical Sciences Sari Iran.
Somayeh SheidaeiDepartment of Laboratory Sciences, Faculty of Paramedical Sciences Mazandaran University of Medical Sciences Sari Iran.
Ali Asghar AlamianDepartment of Orthopedics, Faculty of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.
Hossein SadeghiGenomic Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Mohsen HeidaryDepartment of Laboratory Sciences, School of Paramedical Sciences Sabzevar University of Medical Sciences Sabzevar Iran.ORCID https://orcid.org/0000-0002-9839-5017
Mazandaran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRImam Khomeini Hospital · IRSabzevar University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vanishing bile duct syndrome (VBDS) has been postulated that may be related to Hodgkin's lymphoma (HL). In the present study, we present a 75-year-old male patient with HL who received chemotherapy but has not received any radiotherapy. The patient's condition worsened in further days, and he died with the diagnosis of cirrhosis and hepatic failure.

Indexed as

ductopeniaHodgkin's lymphomaliver failurevanishing bile duct syndrome

Identifiers

PMID37484745
PMCPMC10357002
OpenAlexW4384936895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.